LANOXIN ELIXIR Izraēla - angļu - Ministry of Health

lanoxin elixir

padagis israel agencies ltd, israel - digoxin - elixir - digoxin 0.05 mg / 1 ml - digoxin - digoxin - lanoxin is indicated whenever digitalis therapy is required for the treatment of congestive heart failure, atrial fibrilation and/or flutter and supra-ventricular tachycardia.

PEDIATRIC DIGOXIN INJECTION C.S.D. LIQUID Kanāda - angļu - Health Canada

pediatric digoxin injection c.s.d. liquid

sandoz canada incorporated - digoxin - liquid - 0.05mg - digoxin 0.05mg - cardiotonic agents

DIGOX- digoxin tablet Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

digox- digoxin tablet

tya pharmaceuticals - digoxin (unii: 73k4184t59) (digoxin - unii:73k4184t59) - digoxin 125 ug - digoxin is indicated for the treatment of mild to moderate heart failure. digoxin increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. where possible, digoxin should be used with a diuretic and an angiotensin-converting enzyme inhibitor, but an optimal order for starting these three drugs cannot be specified. heart failure: digoxin is indicated for the control of ventricular response rate in patients with chronic atrial fibrillation. atrial fibrillation: digitalis glycosides are contraindicated in patients with ventricular fibrillation or in patients with a known hypersensitivity to digoxin. a hypersensitivity reaction to other digitalis preparations usually constitutes a contraindication to digoxin.